MAPT and amyloidosis: The observed decreased levels in plasticity-related proteins and increased levels of proteins linked with ChP dysfunction in A+T− have been shown previously.23 Therefore, it seems that both amyloid and tau abnormality drive changes in neuroplasticity and ChP functioning but in a different way.